Literature DB >> 10947909

The use of the electrocardiogram to identify epicardial coronary and tissue reperfusion in acute myocardial infarction.

M Vaturi MD1, Y Birnbaum MD.   

Abstract

The standard 12-lead ECG gives us crucial information concerning myocardial perfusion and the success of reperfusion therapy for ST-elevation acute myocardial infarction. Continuous monitoring has advantages over repeated snapshot recordings. There are four electrocardiographic markers for prediction of the perfusion status of the ischemic myocardium: 1) ST-segment measurements; 2) T-wave configuration; 3) QRS changes; and 4) reperfusion arrhythmias. Complete and stable (> or = 70%) resolution of ST-segment elevation is associated with better outcome and preservation of left ventricular function than partial (30% to 70%) or no (< 30%) ST-segment resolution. Early inversion of the T-waves after initiation of reperfusion therapy is another marker of myocardial reperfusion and a good prognostic sign. Using standard 12-lead ECG, dynamic changes in Q-wave number, amplitude and width, R-wave amplitude and S-wave appearance are detected during reperfusion therapy. However, the significance of these changes have not been clarified. Reperfusion arrhythmias, especially bradycardia and accelerated idioventricular rhythm are detected occasionally during reperfusion therapy, but the value of reperfusion arrhythmias as a marker of coronary artery patency is still debatable. Dynamic changes in the QRS complexes, ST-segments and T-waves occur during reperfusion therapy and the days after. While changes in ST-segment amplitude have been extensively studied, the significance of QRS-complex and T-wave changes are less clear, and especially whether changes in the QRS-complex and T-wave may be complementary and additive to ST-segment monitoring. It has remained unclear whether electrocardiographic signs of reperfusion and re-ischemia should be used for therapeutic decision-making in the clinical setting.

Entities:  

Mesh:

Year:  2000        PMID: 10947909     DOI: 10.1023/a:1018794918584

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  71 in total

1.  Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial.

Authors:  J A de Lemos; E M Antman; C M Gibson; C H McCabe; R P Giugliano; S A Murphy; S A Coulter; K Anderson; J Scherer; M J Frey; R Van Der Wieken; F Van De Werf; E Braunwald
Journal:  Circulation       Date:  2000-01-25       Impact factor: 29.690

2.  Assessment of coronary artery patency after thrombolytic therapy: accurate prediction utilizing the combined analysis of three noninvasive markers.

Authors:  S H Hohnloser; M Zabel; W Kasper; T Meinertz; H Just
Journal:  J Am Coll Cardiol       Date:  1991-07       Impact factor: 24.094

3.  Changes in standard electrocardiographic ST-segment elevation predictive of successful reperfusion in acute myocardial infarction.

Authors:  P Clemmensen; E M Ohman; D C Sevilla; S Peck; N B Wagner; P S Quigley; P Grande; K L Lee; G S Wagner
Journal:  Am J Cardiol       Date:  1990-12-15       Impact factor: 2.778

4.  Comparison of the predictive value of ST segment elevation resolution at 90 and 180 min after start of streptokinase in acute myocardial infarction. A substudy of the hirudin for improvement of thrombolysis (HIT)-4 study.

Authors:  R Schröder; U Zeymer; K Wegscheider; K L Neuhaus
Journal:  Eur Heart J       Date:  1999-11       Impact factor: 29.983

5.  1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).

Authors:  T J Ryan; E M Antman; N H Brooks; R M Califf; L D Hillis; L F Hiratzka; E Rapaport; B Riegel; R O Russell; E E Smith; W D Weaver; R J Gibbons; J S Alpert; K A Eagle; T J Gardner; A Garson; G Gregoratos; T J Ryan; S C Smith
Journal:  J Am Coll Cardiol       Date:  1999-09       Impact factor: 24.094

6.  Use of changes in ST segment elevation for prediction of infarct artery recanalization in acute myocardial infarction.

Authors:  P Buszman; A Szafranek; Z Kalarus; M Gasior
Journal:  Eur Heart J       Date:  1995-09       Impact factor: 29.983

7.  Vectorcardiographic monitoring to assess early vessel patency after reperfusion therapy for acute myocardial infarction.

Authors:  M Dellborg; P G Steg; M Simoons; R Dietz; S Sen; M van den Brand; U Lotze; S Hauck; R van den Wieken; D Himbert
Journal:  Eur Heart J       Date:  1995-01       Impact factor: 29.983

8.  Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations.

Authors:  M W Krucoff; M A Croll; J E Pope; K S Pieper; P M Kanani; C B Granger; R F Veldkamp; B L Wagner; S T Sawchak; R M Califf
Journal:  Am J Cardiol       Date:  1993-01-15       Impact factor: 2.778

9.  QRS mapping in the evaluation of acute anterior myocardial infarction.

Authors:  R von Essen; W Merx; R Doerr; S Effert; J Silny; G Rau
Journal:  Circulation       Date:  1980-08       Impact factor: 29.690

10.  Intracoronary thrombolysis in evolving myocardial infarction.

Authors:  W Ganz; N Buchbinder; H Marcus; A Mondkar; J Maddahi; Y Charuzi; L O'Connor; W Shell; M C Fishbein; R Kass; A Miyamoto; H J Swan
Journal:  Am Heart J       Date:  1981-01       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.